Quarterly report (Form 10-Q)
Johnson & Johnson 10-Q for Quarter ended Jun 28, 2026
Filing excerpt
Sales by international companies were $21.5 billion, which represented an increase of 8.7%, including an operational increase of 3.6%, and a positive currency impact of 5.1% as compared to the fiscal six months sales of 2025.